In lung cancer chemoresistance studies, miR-139-5p enhanced the chemosensitivity of NSCLC by inducing apoptosis and reversing the phenomenon of cisplatin (DDP)-induced cellular resistance through inhibiting the PI3K/AKT/caspase-3 pathway (65). Here, PIK3CB is linked to non-small cell lung carcinoma.